Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
1.24 EUR | +7.83% | +1.64% | -46.09% |
5-Tages-Kurse
verzögerte Kurse Deutsche Boerse AG04.06.2024 | 05.06.2024 | 06.06.2024 | 07.06.2024 | |
---|---|---|---|---|
Kurs | 1.32 € | 1.21 € | 1.15 € | 1.24 € |
Veränderung | +7.32% | -8.33% | -4.96% | +7.83% |
Performance
1 Tag | +7.83% | ||
1 Woche | +1.64% | ||
Aktueller Monat | +1.64% | ||
1 Monat | -14.48% | ||
3 Monate | -64.57% | ||
6 Monate | -20.51% | ||
Laufendes Jahr | -46.09% | ||
1 Jahr | -50.00% | ||
3 Jahre | -84.00% | ||
5 Jahre | -87.21% |
Volumen
MärkteBasisdaten
Extremkurse
Indikatoren
Sektorenvergleich - Bio-Therapeutische Medikamente
Name | % | % 5 Tage | % 1. Jan. | % 1 Jahr | Kap. | |
---|---|---|---|---|---|---|
+7.83% | +1.64% | -46.09% | -50.00% | 27.38 Mio. | ||
-0.51% | +6.08% | +18.72% | +45.24% | 125 Mrd. | ||
+0.22% | +2.33% | +14.19% | +33.71% | 108 Mrd. | ||
-1.44% | -0.26% | -4.93% | -7.92% | 24.21 Mrd. | ||
+0.51% | +4.08% | +3.23% | -2.72% | 22.78 Mrd. | ||
-0.54% | -0.36% | -10.44% | -28.20% | 17.96 Mrd. | ||
-0.45% | +0.66% | -41.74% | -33.88% | 16.43 Mrd. | ||
-0.79% | +5.05% | -13.31% | -27.96% | 16.37 Mrd. | ||
+1.43% | -0.32% | +2.44% | +43.54% | 13.58 Mrd. | ||
+5.01% | -5.04% | +27.89% | -2.06% | 11.66 Mrd. | ||
-0.56% | +3.27% | +83.45% | +183.82% | 9.17 Mrd. | ||
-2.13% | +13.90% | -24.26% | -33.87% | 8.31 Mrd. | ||
-0.96% | +1.53% | +8.91% | +48.76% | 7.87 Mrd. | ||
-2.12% | +1.00% | +13.01% | +39.27% | 7.72 Mrd. | ||
-0.60% | -1.77% | -5.61% | +18.86% | 7.29 Mrd. | ||
-1.15% | +14.81% | +37.58% | +48.86% | 6.47 Mrd. | ||
Durchschnitt | +0.23% | +3.02% | +3.94% | +17.22% | ||
Gewichteter Durchschnitt nach Marktkapitalisierung | -0.18% | +3.41% | +9.99% | +26.38% |
Historische Daten
Datum | Eröffnung | Hoch | Tief | Schlusskurs | Volumen |
---|
Monatliche Veränderungen
Jährliche Veränderungen
2024 | -46.09% | ||
2023 | -38.27% | ||
2022 | -26.94% | ||
2021 | -32.45% | ||
2020 | -6.79% | ||
2019 | -18.92% |
- Börse
- Aktien
- A119KH Aktie
- A119KH Aktie
- Kurse Enlivex Therapeutics Ltd.